Orbimed Advisors - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$19,231,533
-28.8%
4,180,7680.0%0.41%
-16.4%
Q2 2023$27,007,761
-14.3%
4,180,7680.0%0.49%
-21.0%
Q1 2023$31,522,991
-25.6%
4,180,7680.0%0.62%
-23.6%
Q4 2022$42,351,180
+2.4%
4,180,7680.0%0.81%
+5.5%
Q3 2022$41,348,000
-12.4%
4,180,768
-5.6%
0.77%
-10.2%
Q2 2022$47,188,000
+15.8%
4,430,768
+6.0%
0.86%
+29.3%
Q1 2022$40,762,000
-31.8%
4,180,7680.0%0.66%
-14.0%
Q4 2021$59,785,000
-28.6%
4,180,7680.0%0.77%
-16.5%
Q3 2021$83,783,000
-38.8%
4,180,768
-32.8%
0.92%
-33.5%
Q2 2021$136,906,000
-50.8%
6,223,019
-24.1%
1.38%
-46.8%
Q1 2021$278,498,000
-17.6%
8,200,768
-2.4%
2.60%
-12.0%
Q4 2020$338,047,0008,400,7682.96%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$17,358,23889.37%
Founders Fund Growth Management, LLC 407,017$1,872,2785.10%
Prosight Management, LP 2,446,000$11,251,6003.57%
Intellectus Partners, LLC 876,633$4,032,5111.28%
Belmont Capital, LLC 510,000$2,346,0001.27%
Casdin Capital, LLC 2,360,129$10,856,5931.20%
GUARDIAN CAPITAL ADVISORS LP 1,786,414$7,842,3570.88%
Baker Brothers Advisors 20,763,323$95,511,2860.55%
BRANDYWINE MANAGERS, LLC 56,976$262,0900.44%
Orbimed Advisors 4,180,768$19,231,5330.41%
View complete list of ABCELLERA BIOLOGICS INC shareholders